Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: Patient-reported outcomes from the PALOMA-3 trial

N. Harbeck*, S. Iyer, N. Turner, M. Cristofanilli, J. Ro, F. André, S. Loi, S. Verma, H. Iwata, H. Bhattacharyya, K. Puyana Theall, C. H. Bartlett, S. Loibl

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

91 Scopus citations

Fingerprint

Dive into the research topics of 'Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: Patient-reported outcomes from the PALOMA-3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences